Adrenocorticotropic Hormone and 1,25-Dihydroxyvitamin D3 Enhance Human Osteogenesis in Vitro by Synergistically Accelerating the Expression of Bone-Specific Genes.
Irina L Tourkova,Li Liu,Nareerat Sutjarit,Quitterie C Larrouture,Jianhua Luo,Lisa J Robinson,Harry C Blair
DOI: https://doi.org/10.1038/labinvest.2017.62
IF: 5.511
2017-01-01
Laboratory Investigation
Abstract:To improve definition of the physical and hormonal support of bone formation, we studied differentiation of human osteoblasts in vitro at varying combinations of ACTH, 1 α ,25-dihydroxyvitamin D 3 (1,25(OH) 2 D), and extracellular calcium, with and without added cortisol. Bone mineralization, alkaline phosphatase activity, and osteoblast-specific markers RunX2, osterix, and collagen I increased with 10 pM ACTH, 10 nM 1,25(OH) 2 D, or at 2 mM calcium with important synergistic activity of combinations of any of these stimuli. Signals induced by ACTH at 10–30 min included cAMP, TGF- β , and Erk1/2 phosphorylation. Affymetrix gene expression analysis showed that 2 h treatment of ACTH or 1,25(OH) 2 D increased the expression of bone regulating and structural mRNAs, including collagen I, biglycan, the vitamin D receptor, and TGF- β . Accelerating expression of these bone-specific genes was confirmed by quantitative PCR. Expression of 1,25(OH) 2 D 1 α -hydroxylase (1 α -hydroxylase) increased with 1,25(OH) 2 D, ACTH, and extracellular calcium from 0.5 to 2 mM. Unlike renal 1 α -hydroxylase, in osteoblasts, 1 α -hydroxylase activity is independent of parathyroid hormone. In keeping with calcium responsivity, calcium-sensing receptor RNA and protein increased with 10 nM ACTH or 1,25(OH) 2 D. Inclusion of 200 nM cortisol or 10 nM ACTH in differentiation media blunted osteoblasts alkaline phosphatase response to 1,25(OH) 2 D and calcium. Our results point to the importance of ACTH in bone maintenance and that extra skeletal (renal) 1,25(OH) 2 D is required for bone mineralization despite 1 α -hydroxylase expression by osteoblasts.